Cell Penetrating Peptides

<p>Cell-penetrating peptides.-&nbsp;Shuttling homeoproteins and their biological significance.-&nbsp;Artificial evolutionary optimization process to improve the functionality of CPPs.-&nbsp;In silico design of chemically modified cell penetrating peptides.-&nbsp;Synthetic Molecular Evolution of Cell Penetrating Peptides.-&nbsp;A native CPP from rattlesnake with therapeutic and theranostic properties.-&nbsp;Synthesis of cell-penetrating peptide coated silica nanoparticles and their physicochemical and biological characterization.-&nbsp;Enhancing the therapeutic potential of extracellular vesicles using peptide technology.-&nbsp;Challenges and methods for the study of CPP translocation mechanisms.-&nbsp;Membrane molecular interactions and induced structures of CPPs.-&nbsp;A single GUV method for revealing the action of cell-penetrating peptides in biomembranes.-&nbsp;Methods for Small-Angle Scattering Measurements on Peptiplexes of DNA with Cell-Penetrating Peptides.-&nbsp;Imaging CPP delivery mechanisms of oligonucleotides.-&nbsp;Quantitative subcellular analysis of cyclic cell-penetrating peptide EJP18 in non-adherent cells.-&nbsp;PepFect14: signaling and transfection.-&nbsp;Utilisation of cell-penetrating peptides for in vivo delivery of bioactive cargo – the effect of nanoparticle formulation.-&nbsp;Protein delivery by PTDs/CPPs.-&nbsp;Protein Delivery to Cytosol by Cell-Penetrating Peptide Bearing a Tandem Repeat Penetration-Accelerating Sequence.-&nbsp;Recombinant transcription factors (TFs) fused to ZEBRA minimal transduction domain (MD) for modulation of mRNA transcripts.-&nbsp;Protein mimicry and the design of bioactive cell penetrating peptides: The genesis of STOPSPERM bioportides.- Lipopeptide pepducins as therapeutic agents.-&nbsp;Delivery of Antibiotics by Cell-Penetrating Peptides to Kill Intracellular Pathogens.-&nbsp;CPP applications in immune modulation and disease therapy.-&nbsp;Cell-penetrating peptides as carriers for transepithelial drug delivery.-&nbsp;New tools for streamlined in vivo homing peptide identification.-&nbsp;Tumor targeting as new therapeutic approach.-&nbsp;Mitochondrial Targeting Probes, drug conjugates and gene therapeutics.-&nbsp;Novel brain penetrating single chain antibodies directed against 3RTau for the Treatment of Alzheimer’s Disease and related Dementias.-&nbsp;Strategies for peptide-mediated cargo delivery to human smooth muscle cells.- Tips and Tools to Understand Direct Membrane Translocation of siRNA-Loaded WRAP-Based Nanoparticles.- Evaluating&nbsp;efficacy of&nbsp;peptide-delivered&nbsp;oligonucleotides using the severe Taiwanese SMA mouse model.-&nbsp;Development of CPP-based methods for delivery of miRNAs into the skin and airways - lessons from cell culture and mouse models.- Endpoint and kinetic approaches for assessing transfection efficacy in mammalian cell culture.-&nbsp;Tissue analysis of lung-targeted delivery of siRNA and plasmid DNA.-&nbsp;Improvement of transfection with PepFects byorganic and inorganic components.-&nbsp;DNA Transfer into Animal Cells Using Stearylated CPP Based Transfection Reagent.-&nbsp;Use of PepFect14 and siRNA for targeted gene silencing in human embryonic stem cells.-&nbsp;CRISPR/Cas9 plasmid delivery through the CPP: PepFect14.-&nbsp;Applications of CPPs in genome editing of plants.-&nbsp;Live Cell Genomics: Cell-specific transcriptome capture and exon-specific RNA binding protein isolation in live tissues and cells.</p>